Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | SQLE | Q14534 | 5/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8998758 | 1.00 | KMT2A (0.52) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11855335 | 0.91 | KMT2A (0.65) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11855332 | 0.91 | KMT2A (0.65) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL10048642 | 0.86 | KMT2A (0.65) | KMT2AMEN1CYP3A4ALOX15MAPT | |
| SCHEMBL11705884 | 0.77 | KMT2A (0.32) | KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL11705878 | 0.77 | KMT2A (0.32) | KMT2AMEN1CYP3A4ALOX15 | |
| SCHEMBL17728711 | 0.75 | — | — | |
| SCHEMBL5137183 | 0.75 | — | — | |
| SCHEMBL5137182 | 0.75 | — | — | |
| SCHEMBL28172282 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2747886-B1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2018-11-14 | — | — | EP | disclosed |
| EP-2970067-B1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH & CIE (CH) | 2017-08-16 | — | — | EP | disclosed |
| US-9714263-B2 | Selective hydrogenation of aldehydes with Ru/bidentate ligands complexes | FIRMENICH SA (CH) | 2017-07-25 | — | — | US | disclosed |
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2016-02-11 | — | — | US | disclosed |
| US-9090534-B2 | Selective hydrogenation of aldehyde with ru/bidentate ligands complexes | FIREMENICH SA (CH) | 2015-07-28 | — | — | US | disclosed |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | FIRMENICH SA (CH) | 2014-08-28 | — | — | US | disclosed |
| EP-0258967-B2 | Process for producing optically active alcohols | TAKASAGO PERFUMERY CO LTD (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-4962242-A | HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX | TAKASAGO PERFUMERY CO., LTD. (JP) | 1990-10-09 | — | — | US | disclosed |
| EP-0258967-A2 | Process for producing optically active alcohols | Takasago Perfumery Co., Ltd. (JP) | 1988-03-09 | — | — | EP | disclosed |
| US-3953524-A | Catalytic hydrogenation of alpha,beta-unsaturated aldehydes to alpha,beta-unsaturated alcohols | HOFFMANN-LA ROCHE INC. (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039853-A1 | SELECTIVE HYDROGENATION OF ALDEHYDES WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, ADH1C | KMT2A 3791/4885MEN1 3642/4885CYP3A4 307/4885 |
| US-20140243526-A1 | SELECTIVE HYDROGENATION OF ALDEHYDE WITH RU/BIDENTATE LIGANDS COMPLEXES | ADH5, ADH1A, HAO2 | KMT2A 2663/4885MEN1 3990/4885CYP3A4 480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.